News: PerkinElmer Inc (PKI.N)
14 Mar 2014
Thu, Jan 30 2014
Jan 30 - Scientific instruments maker PerkinElmer Inc on Thursday forecast full-year earnings in line with current Wall Street estimates and its CEO sees a rosier 2014 after a year filled with uncertainty in the markets it serves.
- Scientific instruments maker PerkinElmer Inc on Thursday reported a higher-than-expected fourth quarter profit and forecast 2014 earnings in line with current Wall Street estimates.
Jan 30 - Scientific instruments maker PerkinElmer Inc on Thursday reported a higher-than-expected fourth quarter profit and forecast 2014 earnings in line with current Wall Street estimates.
Oct 30 - Scientific instruments maker PerkinElmer Inc narrowed its full-year earnings forecast range on Wednesday, lowering the top end by 3 cents, as it takes a cautious view on business for the rest of the year.
Oct 30 - PerkinElmer Inc on Wednesday reported slightly higher-than-expected third quarter profit and the scientific instruments maker narrowed its full-year earnings forecast range, lowering the top end by 3 cents.
- Bryan Brokmeier Remains Bullish On Life Sciences Tools And Diagnostics Companies
- Excellence At Spectris Has Not Gone Unrewarded
- PerkinElmer Management Discusses Q4 2013 Results - Earnings Call Transcript
- Q4 2013 Perkinelmer Inc Earnings Conference call (Webcast)
- Jim Cramer's 6 Stocks in 60 Seconds: PKI WYNN LINE HFC WEN BSX (Update 1)
- PerkinElmer Management Discusses Q3 2013 Results - Earnings Call Transcript
- PerkinElmer to Present at Cowen and Company 34th Annual Healthcare Conference
- PerkinElmer Announces Financial Results for the Fourth Quarter of 2013
- PerkinElmer to Present at Leerink Global Healthcare Conference
- PerkinElmer Board Declares Quarterly Dividend
- Multi-Year Contracts, Results Schedules, and Financial Guidance Updates - Research Report on Cigna, PerkinElmer, WuXi PharmaTech, MEDNAX, and WellCare
- PerkinElmer to Hold Earnings Call on Thursday, January 30, 2014
- Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA
- PerkinElmer to Present at J.P. Morgan 32nd Annual Healthcare Conference
- Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer
- New Clinical Trials, Stock Price Movements, and Completed Acquisitions - Research Report on Merck, Lilly, Allergan, PerkinElmer, and Air Methods